• Contact
Wednesday, May 21, 2025
Register
Login
European Press
Advertisement
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation

11 April 2025
in Health
Reading Time: 3 mins read
A A
Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation
ShareShareShareShareShare


According to a study published in the European Journal of Cancer, the fairness and equity of datasets for AI-driven mammogram interpretation might be jeopardized by the underrepresentation of racial and ethnic diversity.
While AI shows promise for enhancing how mammograms are interpreted, particularly in areas where resources are limited, the study’s authors found warning signs regarding the diversity of datasets and the representation of researchers in AI model development, which they said could  “affect the models’ generalizability, fairness and equity.”
For the study, researchers conducted a scientometric review of studies published in 2017, 2018, 2022 and 2023 utilizing screening or diagnostic mammograms for breast cancer detection to “train or validate AI algorithms.”
Of the 5,774 studies identified, 264 met the inclusion criteria. 
“The number of studies increased from 28 in 2017 to 2018 to 115 in 2022 to 2023 – a 311% increase. Despite this growth, only 0-25% of studies reported race/ethnicity, with most patients identified as Caucasian,” the study’s authors wrote. 
“Moreover, nearly all patient cohorts originated from high-income countries, with no studies from low-income settings. Author affiliations were predominantly from high-income regions and gender imbalance was observed among first and last authors.”
The authors concluded: “The lack of racial, ethnic and geographic diversity in both datasets and researcher representation could undermine the generalizability and fairness of AI-based mammogram interpretation.”
Furthermore, recognizing the disparities through diverse dataset collection and comprehensive international collaborations is crucial to guaranteeing fair advancements in breast cancer care.
Study data revealed that algorithms focusing mostly on Caucasian populations could result in inaccurate outcomes and the wrong diagnosis in underrepresented populations. Additionally, patient outcomes may be threatened and current disparities could worsen. 
“The fairness of these AI tools is called into question, as they risk systematically dis-advantaging certain racial, ethnic or socio-demographic groups. To mitigate these issues and ensure that the benefits of AI in BC imaging are equitably distributed, it is essential to prioritize diversity in dataset collection, foster international collaborations that include researchers from lower and middle-income countries and actively incorporate diverse populations in clinical research,” the study’s authors wrote. 
THE LARGER TREND
In February, Google partnered with the Institute of Women’s Cancers, founded by France’s cancer research and treatment center Institut Curie, to study how AI tools can help address cancer, share science-based health information and support postdoctoral researchers with funding. 
The two entities looked into how AI-based tools can help forecast the progression of cancer and the likelihood of relapse for patients, with the goal of developing more accurate and successful treatments.
The researchers focused on hard to treat women’s cancers, including triple-negative breast cancer, an aggressive type of breast cancer that grows and spreads faster than other types. 
In 2024, AI biotech company Owkin partnered with pharma giant AstraZeneca to develop an AI-powered tool designed to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides. 
The aim of the tool is to speed up and increase access to gBRCA testing that some patients may not be considered for.
That same year, Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company offering AI-powered software to help providers better understand cancer risk, joined forces to develop a comprehensive ecosystem for early cancer detection, cancer risk prediction and independent AI to improve clinical workflows.
In May of that year, Lunit acquired Volpara and integrated its AI breast health platforms, including its Scorecard breast density assessment tool, into its line of AI tools for breast cancer detection.
Before it acquired Volpara, Lunit partnered with one of the country’s biggest private healthcare providers to help raise Sweden’s cancer screening capability. 
In 2023, Lunit signed a three-year agreement with Capio S:t Göran Hospital to supply and license its AI-powered mammography analysis software Lunit INSIGHT MMG. The AI tool enabled the hospital to analyze breast images of approximately 78,000 patients yearly.

Credit: Source link

Related Posts:

  • Study: Racial, ethnic minorities are underrepresented in AI mammogram interpretation
    Study: Racial, ethnic minorities are…
  • Study: AI hallucinations limit reliability of foundation models
    Study: AI hallucinations limit reliability of…
  • Eating this fruit daily can lower depression risk by 20%: study
    Eating this fruit daily can lower depression risk by…
  • Men with this issue are 5X more likely to have cancer markers
    Men with this issue are 5X more likely to have…
ShareTweetSendPinShare
Previous Post

Bill proposes Medicare reimbursement for AI-enabled medical devices

Next Post

Who plays Carl Webster on Coronation Street? Inside the private life and Hollywood career of star Jonathan Howard

Next Post
Who plays Carl Webster on Coronation Street? Inside the private life and Hollywood career of star Jonathan Howard

Who plays Carl Webster on Coronation Street? Inside the private life and Hollywood career of star Jonathan Howard

Recommended

Knicks’ ‘problematic’ rebounding was a microcosm of Game 2 loss

Knicks’ ‘problematic’ rebounding was a microcosm of Game 2 loss

22 April 2025
Samsung could start production on AR glasses by 2027

Samsung could start production on AR glasses by 2027

8 May 2025
Agricultural output rises 1.9% in Q1

Agricultural output rises 1.9% in Q1

7 May 2025
The secrets of a meaningful and lifelong grandparent-grandchild bond

The secrets of a meaningful and lifelong grandparent-grandchild bond

17 May 2025
SpotitEarly launches in U.S. with .3M to detect cancer using AI and dogs

SpotitEarly launches in U.S. with $20.3M to detect cancer using AI and dogs

15 May 2025
European Press

European-press.com shares the latest news from Europe and around the world. It covers topics such as business, technology, sports, health, entertainment, and lifestyle. Feel free to get in touch with us!

Disclaimer  Privacy Policy – EU  Imprint 

Contact Us

What’s New Here!

  • Knicks’ Jalen Brunson on why he waved to Celtics fans in Game 5
  • Which country is most likely to win Eurovision according to history?
  • Unilab at 80: Staying the Course, Shaping the Future of Filipino Healthcare
  • Runner who died in Brooklyn Half Marathon revealed to be ex-Minnesota football player

Subscribe to Our Newsletter

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Translate »
European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Entertainment
  • Lifestyle
  • Video

Copyright 2025 © EUROPEAN PRESS All rights on our posts reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
×